
Paradromius Wins FDA Approval for High-Bandwidth BCI Trial
Let Freedom: AI & Business News
00:00
Paradromics' Strategy vs. Competitors
Jeremy contrasts Paradromics' neuron-level, high-density approach with Neuralink and Synchron.
Play episode from 02:24
Transcript


